phase ii/iii gain trial results: atuzaginstat for disease modification in alzheimer’s disease
Published 2 years ago • 180 plays • Length 18:06Download video MP4
Download video MP3
Similar videos
-
2:46
phase ii/iii gain trial of a novel lysine-gingipain inhibitor for the treatment of alzheimer’s
-
9:17
phase ii trial of xpro1595 for the treatment of alzheimer’s disease
-
19:01
gain trial: evidence of target engagement and activity with atuzaginstat in alzheimer’s disease
-
4:23
phase ii trial of ar1001 as a potential treatment for alzheimer’s disease
-
4:55
enhancing trials to prove disease modification in early alzheimer's disease
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
4:22
improving clinical trials for alzheimer’s disease therapies
-
2:33
developing gingipain inhibitors for the treatment of alzheimer’s disease
-
1:32
new hope as alzheimer’s drug slows memory decline in phase 3 trial
-
59:38
clinical trials, fad variants, and the etiology of alzheimer’s disease
-
0:22
groundbreaking phase 3 trial for alzheimer's treatment!
-
0:25
experimental alzheimer's drug shows benefits in phase 3 trial
-
7:14
phase iii admet2 trial of methylphenidate for apathy in alzheimer's disease
-
6:13
clinical trials to combat alzheimer’s disease taking place in tampa bay
-
1:00
what is alzheimer's disease? the importance of clinical trials
-
1:53
clinical trials for alzheimer's disease
-
1:31
phase ii study of lecanemab in early ad
-
1:32
major ongoing clinical trials in ad: aducanumab, donanemab & lecanemab
-
1:44
lift-ad trial for moderate alzheimer’s disease